Normal 0 false false false MicrosoftInternetExplorer4 PDL BioPharma Inc (NASDAQ: PDLI) shares faded 0.3% to $6.81. Credit Suisse lowered the rating on PDL BioPharma from neutral to underperform and reduced the price target from $6.50 to $6.00. Share volume was 596,000, compared to an all-day average of 2.8 million /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}